Cargando…

Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications

OBJECTIVE: To estimate Canadian pharmacy cost savings associated with psychiatric medication prescribing that is guided by combinatorial pharmacogenomic testing in patients switching or augmenting their psychiatric medication. METHODS: Pharmacy claims data from a United States (US) pharmacy benefit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanner, Julie-Anne, Brown, Lisa C, Yu, Kunbo, Li, James, Dechairo, Bryan M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910088/ https://www.ncbi.nlm.nih.gov/pubmed/31849503 http://dx.doi.org/10.2147/CEOR.S224277

Ejemplares similares

Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility
por: Winner, Joel G., et al.
Publicado: (2015)

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
por: Tiwari, Arun K., et al.
Publicado: (2022)

Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
por: Tiwari, Arun K., et al.
Publicado: (2022)

Cost-saving medication therapy management for outpatients
por: Priya, K, et al.
Publicado: (2021)

Pharmacogenomic alerts: Developing guidance for use by healthcare professionals
por: Carter, John‐Paul L., et al.
Publicado: (2022)

The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes
por: Benitez, Joachim, et al.
Publicado: (2015)

Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis
por: Islam, Farhana, et al.
Publicado: (2022)

Psychiatric pharmacogenomic testing in clinical practice
por: Mrazek, David A.
Publicado: (2010)

Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
por: Fields, Eve S, et al.
Publicado: (2016)

Medication reconciliation to support pharmacogenomics implementation
por: Mosley, Scott A., et al.
Publicado: (2022)

Medication Nonadherence in Diabetes: Longitudinal effects on costs and potential cost savings from improvement
por: Egede, Leonard E., et al.
Publicado: (2012)

Potential travel cost saving in urban public-transport networks using smartphone guidance
por: Song, Cuiying, et al.
Publicado: (2018)

Application of pharmacogenomics in psychiatric practice: The road ahead
por: Mohan, Prafull, et al.
Publicado: (2021)

Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis
por: Abdullah, Mohammad M. H., et al.
Publicado: (2017)

Emergency medical care of incarcerated patients: Opportunities for improvement and cost savings
por: Martin, Rebecca A., et al.
Publicado: (2020)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Realities of Pharmacogenomic and Minimizing Misconceptions and Medication Misadventures
por: Duong, Benjamin
Publicado: (2021)

Community Health Workers Bring Cost Savings to Patient-Centered Medical Homes
por: Moffett, Maurice L., et al.
Publicado: (2017)

Estimating Savings Opportunities From Therapeutic Substitutions of High-Cost Generic Medications
por: Socal, Mariana P., et al.
Publicado: (2022)

Systematic review of economic evaluation studies in psychiatric pharmacogenomics
por: Mitropoulou, C., et al.
Publicado: (2021)

Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review
por: Brown, Lisa, et al.
Publicado: (2021)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Saving Costs for Hospitals Through Medical Clowning: A Study of Hospital Staff Perspectives on the Impact of the Medical Clown
por: Gomberg, Jack, et al.
Publicado: (2020)

Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study
por: Parsons, Kelly, et al.
Publicado: (2014)

Potential cost savings with terrestrial rabies control
por: Recuenco, Sergio, et al.
Publicado: (2007)

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

General considerations for integrating pharmacogenomics into mainstream medical practice
por: Patrinos, George P
Publicado: (2010)

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
por: Zhou, Shuqin, et al.
Publicado: (2018)

Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications
por: Lo, Cody, et al.
Publicado: (2020)

Students’ knowledge and views on pharmacogenomic education in the medical curriculum
por: Agrawal, Manju, et al.
Publicado: (2021)

Consistent terminology for medication-related problems in pharmacogenomic cases
por: Polasek, Thomas M., et al.
Publicado: (2023)

The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practice
por: Petry, Natasha J., et al.
Publicado: (2022)

Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population
por: Musich, Shirley, et al.
Publicado: (2015)

Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system
por: Subasri, Mathushan, et al.
Publicado: (2021)

Intersection and Considerations for Patient-Centered Care, Patient Experience, and Medication Experience in Pharmacogenomics
por: Murry, Logan T., et al.
Publicado: (2023)

Beyond the bins: interpreting and discussing pharmacogenomic reports with psychiatric patients
por: Dunlop, Boadie W.
Publicado: (2020)

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
por: Campbell, Ciarán, et al.
Publicado: (2022)

Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020)

Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA
por: Wang, Zhong, et al.
Publicado: (2022)

Canadian Medical Association
Publicado: (1889)

Cannot write session to /tmp/vufind_sessions/sess_c974ltk32vegvciel5bmr29drc